systems, redundancy is evident at another level. Neuroperiod when there is normally little feeding activity, and transmitters, such as norepinephrine and ␥-aminobuduring the lights-off period of normally robust eating. tyric acid, coproduced with NPY in the brain stem and Seemingly, marked diminution of NPY availability at tarthe ARC, respectively, stimulate feeding on their own get sites results in the development of supersensitivity and interact with the NPY-induced response (Horvath to NPY so that amounts of exogenous NPY that are et al., 1997). Whether these coexisting signals represent insufficient to evoke feeding in normal rats stimulate a multiple overlapping appetite-stimulating systems or near normal drive for food. Thus, one can picture a whether they are employed to different extents under vicious circle of internal and external environmental facdifferent circumstances remains to be determined. That tors that result in loss of the tight control on NPY neuthis biological redundancy is vital for energy homeostarosecretion causing either overabundance or low abunsis and eventually species' survival is clearly evident in dance, both of which cause exaggerated and unregutwo types of NPY knockout mice. When NPY knockout lated eating patterns and increased body weight. This mice are crossed with the obese (ob/ob) mouse (Erickrevelation may partly account for the difficulties faced son et al., 1996) , the double mutant progeny have a by physicians in designing therapies to decrease the body weight closer to normal than the ob mutant. This body weight of obese patients. result not only substantiates the importance of the unIf the orexigenic network generates a powerful behavderlying role of NPY, but also strengthened the view that ioral drive, then two basic questions arise: what orchesdisruption in NPY signaling may contribute to human trates dissipation of appetite to terminate the ongoing obesity.
feeding, and are there signals that tonically restrain orex-NPY and Body Weight Regulation igenic signals during the intermeal interval? Neither of Normally, animals rigidly guard their daily body weight these two questions has been specifically addressed. around a set point, which is vulnerable to genetic, enviSince lesions in the lateral hypothalamus produce inanironmental (quality of macronutrients, energy expendition and wasting attributable to a lack of motivational ture, and psychosomatic influence), and hormonal indrive to eat (Bray and Ryan, 1996) , it comes as no sursults. The resultant altered caloric intake may culminate prise that organisms have designed more than one way in one of two extremes: excessive body weight gain and to address these questions. Interestingly, as with the obesity, or anorexia and wasting. There is considerable trigger for appetite, both termination and tonic restraint support for the hypothesis that the rigid body weight of eating behavior may be chemically addressed, enmaintenance is attained through multiple satiety signals compassing both the neural and hormonal pathways. that intervene to terminate an ongoing meal and also
In the forebrain, a spectrum of locally produced neuroregulate the intermeal intervals (Bray and Ryan, 1996;  modulators can inhibit intake in various experimental Spiegelman and Flier, 1996) . Physiologically, this may paradigms. It is possible that some of these may reprebe relevant, but now it appears that satiety signaling can sent the physiologically relevant "off" switches. Unlike be overwhelmed by an onslaught of orexigenic signals, cholecystokinin, a well-studied putative satiety signal, especially NPY. Overabundance of NPY produces hyseveral of these anorectic neuromodulators seem to experphagia and abnormal body weight gain (Bray and ert their anti-appetite effects largely through interruption Ryan, 1996; . Intriguingly, low abunof NPY efflux and action at postsynaptic levels within dance of NPY in the hypothalamus, as that produced the hypothalamus. This list includes peptide members by lesions in the ventromedial hypothalamus (VMH), also of the corticotropin-releasing factor family (Spina et al., up-regulates appetite to the extent that animals eat equally throughout the day, both during the lights-on 1996), glucagon-like peptide-1 (Turton et al., 1996), me-lanocyte-stimulating hormone acting through melanohormonal signals are key components of the longsought peripheral negative feedback link that acts cortin-4 receptors (Fan et al., 1997) , and serotonin interfering drugs, such as d-fenfluramine, the active comthrough a central orexigenic network for weight control (Figure 1) . ponent of the currently in-vogue diet pill Redux, and the other serotonin reuptake blocker, fluoxitine (Kalra and Whereas this identification of putative key facets of the "lipostat" theory generated an immediate all-round . One can now add to this list the cytokines, such as ciliary neurotrophic factor, an endogenous anoexcitement, further validation through analysis of circulating levels of leptin in rodents and humans has been rectic and cachectic agent during infection and disease that acts by blocking NPY synthesis, release, and postless than encouraging. Contrary to expectations, circulating leptin levels are generally at their lowest during synaptic action (Kalra et al., 1996, Soc. Neurosci. abstract) .
the intermeal intervals and rise either as part of the innate daily rhythm or long after initiation of intake. FurThe amount of body fat can be regulated by various peripheral hormonal signals. One of these, pancreatic thermore, a strong positive correlation between plasma leptin levels and body fat mass has been found, suginsulin, acts via the hypothalamus to control appetite and energy expenditure (Bray and Ryan, 1996; Spiegel- gesting that leptin production is regulated by the mass of adipocytes. The fact that circulating levels are highly man and Flier, 1996) . This large circulating protein is transported across the blood-brain barrier endothelium variable among individuals and are either in the normal range or elevated in obese individuals argues against into the cerebrospinal fluid by an active process, and one of the central sites of its action to suppress feeding the leptin-deficiency hypothesis as the cause of unregulated eating and obesity in most cases (Spiegelman and is the paraventricular nucleus . Insulin suppresses NPY release from the nerve terminals Flier, 1996; Considine et al., 1996a Considine et al., , 1996b Maffei et al., 1996) . It is possible that defective transport to the central rapidly enough to support the possibility that the postprandial rise in insulin may terminate NPY-dependent nervous system, extremely rapid development of resistance, and/or tolerance to the action of leptin in the eating episodes. However, the efficacy of insulin as the primary hormonal signal in body weight control has been hypothalamus may be common in obese individuals. Further, unlike the receptor variants detected in diaquestioned because of the fact that hyperinsulinemia generally accompanies hyperphagia and obesity in man betic, obese db/db mice, the OB-R appears to be no different in eight obese and lean individuals examined and experimental models.
The "lipostat" hypothesis has been an enduring proso far (Considine et al., 1996a) , giving rise to the idea of a defective postreceptor downstream leptin signal posal to explain the tight control on body weight (Zhang et al., 1994; Spiegelman and Flier, 1996) . It predicts that transduction underlying the hypothalamic insensitivity to leptin. secretions from fat cells may be the key signals to the brain to regulate feeding and body fat deposition. One
The VMH lesion-induced rodent obesity model provides clues to this puzzle of high leptin production conof these secretory products is encoded by the recently cloned mouse obese (ob) gene and its counterparts in comitant with unregulated phagia and excessive rate of body weight gain (Dube et al., 1996 , Soc. Neurosci. other species, including humans (Zhang et al., 1994 ). This identification was followed in quick succession by abstract). Soon after the production of chemical lesions with no apparent structural damage in the VMH and characterization of 16-kd protein, leptin (Leptos ϭ thin), establishing its efficacy in normalizing body weight and after electrolytic lesions in the VMH, leptin production is exaggerated concomitant with reduced availability appetite in leptin-deficient ob/ob mice by systemic and central injections (Campfield et al., 1995; Spiegelman of NPY in the paraventricular nucleus and loss of the regulated daily pattern of feeding (Spiegelman and Flier, and Flier, 1996) , and most recently cloning of its receptor (Tartaglia et al., 1995) . The leptin receptor (OB-R), a 1996; Dube et al., 1996, Soc. Neurosci. abstract; . The resultant hyperphagia and steady gain product of the db gene, which has been long believed to encode the receptor for a weight-controlling hormone, is in weight, as mentioned above, may be a consequence of rapid development of NPY receptor supersensitivity expressed as various splice variants in the rodent and human hypothalamus (Considine et al., 1996a; ( Figure 1 ; Dube et al., 1996, Soc. Neurosci. abstract; . Thus, thorough examination of the al., 1996; Mercer et al., 1996) .
Significant new insights into the relationship between cellular and molecular bases of the shifts in receptor dynamics of orexigenic signals accompanying weight peripheral signals, insulin, and leptin, and their impact on the orexigenic network (Figure 1 ) have provided some disorders is warranted. Notwithstanding these complexities, a neural timing critical missing pieces in the "lipostat" puzzle. Insulin up-regulates leptin synthesis and release from adipomechanism also operates upstream from the orexigenic network in the daily management of energy hocytes, and leptin has been shown to cross the bloodbrain barrier via the parenchymal compartment (Bray meostasis (Figure 1) . Although the precise anatomical boundaries are not clearly defined, this device is likely and Ryan, 1996; Spiegelman et al., 1996) . An important central action of leptin is likely to be inhibition of NPY to be composed of a group of neurons that integrate incoming internal and external environmental informarelease and synthesis in the ARC of the hypothalamus and possibly inhibition of the postsynaptic appetitetion for the timely onset of the drive to eat. Whether this network operates independently as evident in primates, stimulating effects of NPY (Stephens et al., 1995) . The findings that insulin and leptin each inhibit NPY release or whether it is entrained to the circadian timekeeper, the hypothalamic suprachiasmatic nucleus, as in most and that insulin has the potential to up-regulate leptin output together support the likelihood that these two other mammals, remains to be ascertained. Intriguingly, Spiegelman, B.M., and Flier, J.S. (1996) . Cell 87, [377] [378] [379] [380] [381] [382] [383] [384] [385] [386] [387] [388] [389] the VMH has also been suspected as an integrated con- revelations that both over-and underexpression of hypothalamic NPY result in unregulated eating and body weight gain, in conjunction with resistance to insulin and leptin, underscore a new rationale for designing therapeutic strategies to control appetite and body weight. Seemingly, the efficacy of anti-appetite drugs will depend both on their effectiveness to curtail the availability of orexigenic messenger molecules at the target sites while preventing the development of receptor supersensitivity.
